Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Norway Royal Salmon ASA (NRS): NTS ASA – Increase of the Offer Price to NOK 240 per in the mandatory offer to acquire Shares in Norway Royal Salmon ASA – extension of the offer period

This is a copy of the stock exchange announcement from NTS ASA at 21:30 today. NTS ASA («NTS» or the Offeror») has today agreed to acquire in total 378,883 shares in Norway Royal Salmon ASA (“NRS” or the Company”) at NOK 240 per share, equal to approximately 0.87 % of the total number of issued and outstanding shares in NRS. 95 529 of the shares acquired were acquired from related parties of the NTS CEO Harry Bøe, and 39, 384 of the shares were acquired from NTS Chairman of the Board Odd Reidar Øie and related parties. The Offeror thus own directly and indirectly, taking into

Brighter Commences Legal Action Against Unwrap Finance Nordic AB

Brighter AB (publ) (“Brighter” or “the Company”) announced today that the Company has commenced legal action in Attunda District Court against Unwrap Finance Nordic AB ("Unwrap" or “the Counterparty”) to enforce the payment of debts owed to the Company. The legal action relates to certain potential claims mentioned by the Company's auditor in the Annual Report 2020 relating to an investment made in certain debt certificates issued by Unwrap (see press release dated 31 May 2021, Brighter's Auditor Makes Certain Recommendations in the Audit Report for the Fiscal Year 2020 

President and CEO Rasmus Nerman leaves Humana

Humana's President and CEO Rasmus Nerman has informed the Board that he has decided to leave the company, as he has accepted the role of President and CEO of Apoteket AB. The Board is now starting the process of recruiting his successor.After eight years at Humana and six years as President and CEO, Rasmus Nerman leaves the company at his own request. ‒ I have decided to leave Humana for a new challenge and have accepted to become President and CEO of Apoteket AB. I am incredibly proud of Humana's development and I feel very grateful to have been entrusted to lead Humana that has such an

Curando Nordic: Vo2 Cap Holding AB (publ) publishes company description (Cision)

Company description in this case is published today on Curando's website www.curandonordic.se.Full press release: Vo2 Bolagsbeskrivning ‍2021-08-11 16:51 THEINFORMATION IN THIS PRESS RELEASE IS NOT INTENDED TO BE PUBLISHED, PUBLISHED, OR DISTRIBUTED, DIRECTLY, OR IMMEDIATELY, OR , HONG KONG, CANADA, SINGAPORE, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION SHALL BREACH APPLICABLE LAWS OR RULES. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE. The current company Curando Nordic AB (publ) (

Alcadon signs agreement with Deutsche Glasfaser, a leading German provider of FTTH, concerning delivery of products for the FTTH roll-out in Germany with an estimated value of EUR 20 mill per year

Alcadon has through its German Subsidiary Alcadon Gmbh signed a 3 + 1 year contract for delivery of fiber optic materials for the FTTH (Fiber-To-The-Home) build out with Deutsche Glasfaser. It includes deliveries to all contractors for the expansion the FTTH network. The deliveries will commence December 2021. The estimated value of the contract with Deutsche Glasfaser is Euro 20 mill per year.Company group Deutsche GlasfaserThe Deutsche Glasfaser group of companies plans, builds and operates mainly provider-open direct fibre optic connections for private households and companies. It is

Tecnotree Corporation’s share issue to the company itself without consideration

Tecnotree Corporation Stock Exchange Release 11 Aug 2021 at 19:00 EETThe Board of Directors of Tecnotree Corporation has, based on the authorization granted by the Annual General Meeting of Shareholders on 15 May 2019, resolved to issue 5,750,000 new shares to the company itself without consideration in accordance with chapter 9 section 20 of the Limited Liability Companies Act. The shares are of the same series as the company’s other shares and entitle to the same shareholder rights as the company’s existing shares after their registration. The new shares to be issued to the company

Cereno Scientific and Abbott enter collaboration for use of cutting-edge monitor device in upcoming Phase II study with CS1

Cereno Scientific (XSAT: CRNO B) today announced that a collaboration agreement has been entered with global healthcare company Abbott regarding use of its CardioMEMS™ HF System in the upcoming Phase II study with Cereno’s drug candidate CS1. The technology will be used to remotely and continously monitor the pulmonary pressure in the Phase II study evaluating CS1 for the treatment of pulmonary arterial hypertension (PAH). The CardioMEMS device allows Cereno to use a smaller-sized patient population for the Phase II study, which is both more time and cost efficient.“We are passionate about

H1 2021 Interim Financial Report: solid demand across all markets led to strong organic growth and historical high earnings

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first half of 2021 (“H1 2021”). CEO Michael T. Andersen quote “Our markets have quickly recovered from the slowdown seen in early in the year caused by harsh weather conditions and Q2 2021 has showed solid demand across all markets leading to strong organic growth and historical high earnings for H+H—both for the quarter and for the half-year period. The UK market in particular has showed very strong demand and H+H is producing at

Nel ASA: Receives contract for a 1.25 MW containerized PEM electrolyzer for DOE H2@Scale project in the US

(Oslo, 11 August 2021) Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a contract for a 1.25 megawatt (MW) containerized PEM electrolyzer from a leading utility in the US. Nel Hydrogen US has received a purchase order for a 1.25 MW PEM electrolyzer for installation at a nuclear power plant in the US, a groundbreaking project for carbon-free hydrogen production.  “This project represents an important first step toward developing a regional supply of zero carbon hydrogen, while supporting clean baseload electricity resources on the grid,” says Stephen Szymanski, Vice

Erik Penser Bank has published a Q&A with Attana’s CEO and Head of Diagnostics

Earlier today, Erik Penser Bank published an interview with Attana’s CEO, Teodor Aastrup, and Head of Diagnostics, Samir Fostock, who answer questions from shareholders.The interview, led by equity research analyst Johan Löchen, is held in Swedish and answers questions regarding: · Why did Attana start a new business area within diagnostics? · What is the current status of Attana Diagnostics? · What is the product offering? · What is the sales and marketing strategy? · What does the regulatory plan look like? · How does Attana’s technology differ from ELISA-based

Invitation to presentation of Embracer Group’s Q1 report

Embracer Group hereby invites you to a presentation in connection with the publication of the interim report for the first quarter, the period April-June 2021. The report will be published at 06.00 (CEST) on August 18th and available as of this time at: www.embracer.comThe presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterwards a Q&A session will follow, led by analyst Oscar Erixon from Carnegie. Covid-19 Embracer Group safeguards stakeholders' health and strives to help limit the spread of the coronavirus, as well as comply with applicable

ABS and yellow.ai Bring Conversational AI to My Digital Fleet

Technology Capable of Conversing in 100+ Languages Delivers Insights for Shipowners and Charterers in a Significant Industry First(HOUSTON) ABS is launching enterprise-grade, AI-powered chatbots and voicebots on its ABS My Digital Fleet™ risk management platform together with yellow.ai, the world’s leading Conversational AI Platform. This marks an important industry first as no such digital solution has previously been deployed to provide shipping companies with helpful information and support in a conversational manner on a global scale. It is the latest addition to ABS My Digital Fleet’s

#21-268 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-267 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Invitation to Presentation of Immunovia’s Interim Report January – June 2021

LUND (SWEDEN) – Immunovia will publish the company’s interim report for the period January 1 – June 30, 2021 on Thursday, August 19, 2021 at 16:00 CEST. Investors, analysts and media are invited to a telephone conference with web presentation on the same day at 16:30 CEST. CEO Patrik Dahlen will present Immunovia and comment on the interim report. Medical Director Dr. Thomas King, Sr. Marketing Director US Cindy Callahan and CEO Patrik Dahlen will also provide an update about the marketing plans following the launch of the IMMRay[TM]  PanCan-d test. The presentations will be held in

Update on US review of roxadustat

11 August 2021 14:35 BST Update on US regulatory review of roxadustatin anaemia of chronic kidney disease The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anaemia of chronic kidney disease (CKD), in both non-dialysis dependent (NDD) and dialysis-dependent (DD) adult patients. The CRL requested an additional clinical trial on the safety of roxadustat in both the NDD and DD patient populations. AstraZeneca is working with its partner FibroGen, Inc. (FibroGen) and the

Axactor SE - Invitation to presentation of Q2 2021 results

Axactor SE will present the Q2 results 2021 on Tuesday August 17th 2021.The presentation will take place at Hotel Continental, Stortingsgata 24/26, Oslo at 08.30 (CET) The presentation will be held in Norwegian. For attendance at Continental please send an e-mail to Liv Øverby (liv.overby@axactor.com) In addition, there will be a global investor webcast with a live Q&A session at 10.00 (CET). The webcast will be held in English. CEO Johnny Tsolis will present the results. Webcast participation will be possible via the following: Webcast URL: https://streams.eventcdn.net/

Neonode Reports Quarter Ended June 30, 2021 Financial Results

STOCKHOLM, SWEDEN – August 11, 2021 – Neonode Inc. (NASDAQ: NEON), today reported financial results for the three and six months ending June 30, 2021. FINANCIAL SUMMARY FOR THE QUARTER ENDED JUNE 30, 2021: · Revenue of $1.7 million, an increase of 127% compared to the same period in the prior year. · Operating expenses of $3.3 million, an increase of 37.8% compared to the same period in the prior year. · Net loss of $1.7 million, or $0.14 per share, compared to $1.6 million, or $0.18 per share, for the same period in the prior year. · Cash used by operations of $1.4 million

Nel ASA: Invitation to presentation of Q2 2021 results

(Oslo, 11 August 2021) Nel ASA will announce its second quarter 2021 report on Thursday 19 August at 07:00 CET and will host a presentation at 08:00 CET. The presentation will be held at H7-2, Haakon VIIs gate, Oslo at 08:00 CET. The presenter will be Jon André Løkke, CEO. The presentation will be followed by Q&A based on submitted questions during the call. Due to Covid-19 restrictions, physical participation at the presentation in Oslo will be limited. Please contact ir@nelhydrogen.com to register your interest. A confirmation of participation will be needed to access the event.

Kid ASA - Invitation to presentation of Second quarter 2021 results

Lier, 11 August 2021: Kid ASA will release its second quarter 2021 results on Friday 20 August 2021. The quarterly report and presentation material will be available on http://investor.kid.no and http://newsweb.no from 07:30 CET.To register your attendance and for meeting bookings with Kid management, please contact charlotte.mullins@sb1markets.no at SpareBank 1 Markets. ENQUIRIES: Eystein Lund, CFO Kid ASA, +47 906 02 127

Walmart-owned Sam’s Club opens flagship store in Shanghai and introduces DUG

Sam’s Club is part of the world’s largest department store chain, Walmart Inc., and has about 600 stores, of which 32 are in the Chinese megacities. At the end of September, Sam’s Club will open its third department store in Shanghai and to celebrate this, Sam’s Club will launch Veg of Lund’s plant-based drink DUG[®].Sam’s Club is a chain of membership-only retail warehouse clubs and the range consists of popular products from global brands. Sam’s Club was founded in 1983 and is named after Walmart’s founder Sam Walton. The chain aims to establish up to 45 stores in China and also offers e-

Betsson acquires Inkabet to strengthen its market position in the western region of South America

SW Nordic Limited, a subsidiary of Betsson AB (publ), has signed an agreement to acquire Inkabet’s B2C online gambling business, a rapidly growing sportsbook and casino targeting the western region of South America. The acquisition strengthens and expands Betsson’s presence in Latin America, a strategically important region for the company.SW Nordic Limited, a subsidiary of Betsson AB (publ), has signed an agreement to acquire the business activities, operations and all the related assets used for operating the brand “Inkabet”. The initial consideration of the acquisition is USD 25 million.

Borr Drilling Limited – Announcement of Letter of Award for jack-up drilling rig

Borr Drilling Limited (NYSE and OSE: “BORR”) is pleased to announce it has secured a Letter of Award (“LOA”) for the premium jack-up drilling rig “Gunnlod” from an undisclosed operator in Malaysia. The program is expected to commence in Q4 2021 in direct continuation of the rig's current contract with an approximate duration of 105 days. This LOA, which is expected to be converted into a contract shortly, will maintain the rig contracted over the monsoon season in South East Asia and into Q1 2022, when additional employment opportunities should be available for the rig. Hamilton, Bermuda

ETTEPLAN Q2 2021: Strong and profitable growth

ETTEPLAN Oyj Half Year Financial Report August 11, 2021, at 1:00 pm ETTEPLAN Q2 2021: Strong and profitable growth Key points April-June 2021 · The Group’s revenue grew by 19.3 per cent and was EUR 75.0 million (4-6/2020: EUR 62.9 million). At comparable exchange rates, revenue increased by 18.1 per cent. · Operating profit (EBITA) improved by 24 per cent and was EUR 7.8 (6.3) million, or 10.4 (10.0) per cent of revenue. · Operating profit (EBIT) improved by 25.6 per cent and was EUR 6.7 (5.4) million, or 9.0 (8.5) per cent of revenue. · Operating cash flow was EUR 12.4 (

There are no items matching the current filter
There are no more items matching the current filter
Back to top